Literature DB >> 3773397

[Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence].

N Ishii, H Watanabe, C Irisawa, Y Kikuchi, S Kawamura, K Suzuki, R Chiba, M Tokiwa, M Shirai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3773397     DOI： 10.5980/jpnjurol1928.77.6_954

Source DB:  PubMed          Journal:  Nihon Hinyokika Gakkai Zasshi        ISSN： 0021-5287


× No keyword cloud information.
  7 in total

1.  Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.

Authors:  Dejan Bratus; Gregor Hlebic; Tine Hajdinjak
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

Review 2.  Self-administration in the pharmacological treatment of impotence.

Authors:  F Bénard; T F Lue
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 3.  Intracavernous prostaglandin E1 in erectile dysfunction.

Authors:  O I Linet; L L Neff
Journal:  Clin Investig       Date:  1994-01

Review 4.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

5.  Measurement of intracavernosal catecholamine during a prostaglandin E1 test.

Authors:  Koichi Nagao; Kazukiyo Miura; Nobuhisa Ishii; Masafumi Shirai
Journal:  Reprod Med Biol       Date:  2002-05-16

6.  Metabolism studies on transdermal prostaglandin E1 in human foreskin in vitro.

Authors:  M Foldvari; C J Oguejiofor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Apr-Jun       Impact factor: 2.569

7.  The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction.

Authors:  Xu-Jun Xuan; Gang Bai; Cai-Xia Zhang; Chao Xu; Fu-Ding Lu; Yang Peng; Gang Ma; Cong-Hui Han; Jun Chen
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.